Anti-aging therapies may have settled the argument of whether aging is a disease.

This Clarity Insight was the result of the many requests for help and engagement with CCRM Australia by biotechnology companies that have anti-aging technologies. We started to reflect if aging was a disease and if not, should their complex manufacturing processes be regulated as if they were biological medicines?